November 14, 2024
Loading...
You are here:  Home  >  'Thousand Oaks'  -  Page 74
Latest

Teledyne’s second quarter revenues, profits, earnings per share down

By   /  Thursday, August 4th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Teledyne’s second quarter revenues, profits, earnings per share down

Teledyne Technology revenues fell, profits fell and earnings per share fell during the second quarter, the company announced when it released second quarter earnings results Aug. 4. The Thousand Oaks-based industrial conglomerate saw second quarter revenues fall 6.7 percent from $573.6 million in 2015 to $534.9 million in 2016, which missed analyst estimates of $546.7 Read More →

Latest

Inphi completes sale of Rambus

By   /  Thursday, August 4th, 2016  /  Latest news, Technology  /  1 Comment

Inphi completed the sale of its memory product business to Sunnyvale-based Rambus Aug. 4. The Santa Clara-based Inphi, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business. As part of the Read More →

Latest

CVS Health will not cover Amgen’s Neupogen in favor of Novartis biosimilar

By   /  Thursday, August 4th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on CVS Health will not cover Amgen’s Neupogen in favor of Novartis biosimilar

CVS Health will no longer cover Thousand Oaks-based Amgen’s Neupogen on its standard drug plan in 2017, favoring the biosimilar Zarxio from Novartis. CVS, which is the second largest benefits manager behind Express Scripts and also owns the largest chain of drug stores in the U.S., said Aug. 2 it will choose biosimilar drugs over Read More →

Latest

Amgen buying rights to Advaxis cancer treatment

By   /  Tuesday, August 2nd, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on Amgen buying rights to Advaxis cancer treatment

Thousand Oaks-based biotech giant Amgen said it will buy the rights to develop and commercialize a cancer immunotherapy treatment Aug. 2. Under the agreement, Amgen will pay Princeton, N.J.-based Advaxis $40 million and buy $25 million worth of Advaxis common stock for the rights to develop and commercialize a preclinical cancer immunotherapy, which is designed Read More →

Latest

Land O’Lakes completes Ceres acquisition

By   /  Monday, August 1st, 2016  /  Agribusiness, Latest news, Technology  /  Comments Off on Land O’Lakes completes Ceres acquisition

Minneapolis-based Land O’Lakes completed its acquisition of Thousand Oaks-based ag-biotech company Ceres on Aug. 1. On June 17, Land O’Lakes, an ag and food conglomerate that had $13 billion in sales in 2015, announced it would buy Ceres for $17.2 million. For about two decades, Ceres had been devoted to developing biofuels using crops like Read More →

Latest

Ventura County businesses win as NFL’s Rams returns to LA

By   /  Friday, July 29th, 2016  /  East Ventura County, middle, Small Business, Tri-County Economy, West Ventura County  /  Comments Off on Ventura County businesses win as NFL’s Rams returns to LA

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Tax measures could alter tri-county marijuana market

By   /  Friday, July 29th, 2016  /  Agribusiness, Health Care & Life Science, left  /  Comments Off on Tax measures could alter tri-county marijuana market

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.